Back to search

Phase Biolabs Ltd

12602104

active
Private Limited Company
Companies House
Health Score
70 / 100

Some Concerns

30/30
Filing
0/30
Financial
40/40
Risk
  • Negative net worth (-10)
  • Current liabilities exceed current assets (-10)
  • Going concern doubt noted in accounts (-10)

Details

SUITE 2540, 37 WESTMINSTER BUILDINGS, NOTTINGHAM, NG1 6LG
Incorporated 14/05/2020

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72110
Research and experimental development on biotechnology

Officers

David Ortega Raymundo

director · Since 14/05/2020

MANAGING DIRECTOR

SPANISH · ENGLAND · Age 37

Persons with Significant Control

David Ortega Raymundo

75–100% shares
75–100% votes
Appoint directors

Spanish · England · Age 37

Suite 2540,, 37 Westminster Buildings, Nottingham, NG1 6LG

Notified 14/05/2020

CompanyRankvs 2100+ SIC 72110 peers
35

Financial strength14th percentile among SIC peers · 4/25
Employees93th percentile among SIC peers · 14/15
LiquidityCurrent ratio 0.88× · 6/20
Longevity6 years trading (max 15) · 6/15
Filing complianceAll filings up to date · 15/15
Going concern doubt -10
Show leaderboard
1Werfen Limited
90
2Biopharma Process Systems Limited
90
3Theradex (Europe) Limited
90
4Spicer Consulting Limited
90
5Exmoor Pharma Concepts Limited
90
6Ubc Late Stage (Uk) Limited
90
7Wuxi Apptec Uk Ltd
90
8Bio - Diagnostics Limited
89
9Biointeractions Limited
89
10Ams Advanced Medical Services Limited
89
2100Phase Biolabs Ltd
41
How is this score calculated?
Financial strength4/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees14/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity6/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity6/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Going concern doubt: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Going Concern Doubt

the UK and Republic of Ireland” including the provisions of Section 1A “Small Entities” and the Companies Act 2006. The financial statements have been prepared under the historic cost convention. Going concern In preparing these financial statements, the director has assessed whether there are any material uncertainties related to events or conditions that cast significant doubt upon the compan

Key FinancialsYear ending 31/12/2024

Net Worth

-£20k

Balance sheet strength

Cash

£7k

Cash in the bank

Net Current Assets

-£176k

Working capital

Current Assets

£1.3M

Current Liabilities

£1.5M

Fixed Assets

£260k

Debtors

£1.3M

12avg. employees+11

Balance Sheet

Assets less current liabilities£83k
Signed by Mr D Ortega Raymundo,Prepared with IRIS Elements Accounts Production

EstimatesDerived

YearCurrent RatioImplied Profit
20240.88-£39k
20210.15+£14k
20210.69—

Derived from filed accounts. Not audited figures.